FDA Orange Book · active-ingredient family
Luliconazole
Luliconazole is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:LUZU · NDA 204153
1
Brand (NDA)
0
Generics (ANDA)
4
Listed patents
0
Exclusivity periods
Brand (NDA) products · cream
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| LUZURLD | BAUSCH | NDA 204153 | — | Nov 14, 2013 |
Listed patents (4)
| Patent | Expires | In | Type |
|---|---|---|---|
| 9012484 | Sep 06, 2033 | in 7 yr 4 mo | SubstanceProductU-540 |
| 9453006 | Sep 06, 2033 | in 7 yr 4 mo | Substance |
| 9199977 | Sep 06, 2033 | in 7 yr 4 mo | SubstanceProduct |
| 8980931 | Apr 28, 2034 | in 8 yr | Product |
Luliconazole — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
